| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |